Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

The initial presentation of non-alcoholic steatohepatitis (NASH) is hepatic steatosis. The dysfunction of lipid metabolism within hepatocytes caused by genetic factors, diet, and insulin resistance causes lipid accumulation. Lipotoxicity, oxidative stress, mitochondrial dysfunction, and endoplasmic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clinical and molecular hepatology Ročník 29; číslo 1; s. 77 - 98
Hlavní autoři: Lee, Kuei-Chuan, Wu, Pei-Shan, Lin, Han-Chieh
Médium: Journal Article
Jazyk:angličtina
Vydáno: Korea (South) Korean Association for the Study of the Liver 01.01.2023
The Korean Association for the Study of the Liver
대한간학회
Témata:
Autophagy
Body fat
Diet
Exercise
Fatty acids
Fatty liver
Fibrosis - etiology
Humans
Inflammation
Inflammation - metabolism
Inflammation - pathology
Insulin Resistance
Kinases
Lipids
Liver - pathology
Liver cancer
Liver cirrhosis
Liver diseases
liver fibrosis
Metabolism
MicroRNAs
Non-alcoholic Fatty Liver Disease - drug therapy
Non-alcoholic Fatty Liver Disease - pathology
Non-alcoholic Fatty Liver Disease - therapy
Obesity
Overweight
Oxidation
Oxidative stress
Pathogenesis
Phosphorylation
Proteins
Review
Sedentary behavior
steatohepatitis
내과학
Steatohepatitis
Fatty liver
Liver fibrosis
ISSN:2287-2728, 2287-285X, 2287-285X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract The initial presentation of non-alcoholic steatohepatitis (NASH) is hepatic steatosis. The dysfunction of lipid metabolism within hepatocytes caused by genetic factors, diet, and insulin resistance causes lipid accumulation. Lipotoxicity, oxidative stress, mitochondrial dysfunction, and endoplasmic reticulum stress would further contribute to hepatocyte injury and death, leading to inflammation and immune dysfunction in the liver. During the healing process, the accumulation of an excessive amount of fibrosis might occur while healing. During the development of NASH and liver fibrosis, the gut-liver axis, adipose-liver axis, and renin-angiotensin system (RAS) may be dysregulated and impaired. Translocation of bacteria or its end-products entering the liver could activate hepatocytes, Kupffer cells, and hepatic stellate cells, exacerbating hepatic steatosis, inflammation, and fibrosis. Bile acids regulate glucose and lipid metabolism through Farnesoid X receptors in the liver and intestine. Increased adipose tissue-derived non-esterified fatty acids would aggravate hepatic steatosis. Increased leptin also plays a role in hepatic fibrogenesis, and decreased adiponectin may contribute to hepatic insulin resistance. Moreover, dysregulation of peroxisome proliferator-activated receptors in the liver, adipose, and muscle tissues may impair lipid metabolism. In addition, the RAS may contribute to hepatic fatty acid metabolism, inflammation, and fibrosis. The treatment includes lifestyle modification, pharmacological therapy, and non-pharmacological therapy. Currently, weight reduction by lifestyle modification or surgery is the most effective therapy. However, vitamin E, pioglitazone, and obeticholic acid have also been suggested. In this review, we will introduce some new clinical trials and experimental therapies for the treatment of NASH and related fibrosis.
AbstractList The initial presentation of non-alcoholic steatohepatitis (NASH) is hepatic steatosis. The dysfunction of lipid metabolism within hepatocytes caused by genetic factors, diet, and insulin resistance causes lipid accumulation. Lipotoxicity, oxidative stress, mitochondrial dysfunction, and endoplasmic reticulum stress would further contribute to hepatocyte injury and death, leading to inflammation and immune dysfunction in the liver. During the healing process, the accumulation of an excessive amount of fibrosis might occur while healing. During the development of NASH and liver fibrosis, the gut-liver axis, adipose-liver axis, and renin-angiotensin system (RAS) may be dysregulated and impaired. Translocation of bacteria or its end-products entering the liver could activate hepatocytes, Kupffer cells, and hepatic stellate cells, exacerbating hepatic steatosis, inflammation, and fibrosis. Bile acids regulate glucose and lipid metabolism through Farnesoid X receptors in the liver and intestine. Increased adipose tissue-derived non-esterified fatty acids would aggravate hepatic steatosis. Increased leptin also plays a role in hepatic fibrogenesis, and decreased adiponectin may contribute to hepatic insulin resistance. Moreover, dysregulation of peroxisome proliferator-activated receptors in the liver, adipose, and muscle tissues may impair lipid metabolism. In addition, the RAS may contribute to hepatic fatty acid metabolism, inflammation, and fibrosis. The treatment includes lifestyle modification, pharmacological therapy, and non-pharmacological therapy. Currently, weight reduction by lifestyle modification or surgery is the most effective therapy. However, vitamin E, pioglitazone, and obeticholic acid have also been suggested. In this review, we will introduce some new clinical trials and experimental therapies for the treatment of NASH and related fibrosis. KCI Citation Count: 1
The initial presentation of non-alcoholic steatohepatitis (NASH) is hepatic steatosis. The dysfunction of lipid metabolism within hepatocytes caused by genetic factors, diet, and insulin resistance causes lipid accumulation. Lipotoxicity, oxidative stress, mitochondrial dysfunction, and endoplasmic reticulum stress would further contribute to hepatocyte injury and death, leading to inflammation and immune dysfunction in the liver. During the healing process, the accumulation of an excessive amount of fibrosis might occur while healing. During the development of NASH and liver fibrosis, the gut-liver axis, adipose-liver axis, and renin-angiotensin system (RAS) may be dysregulated and impaired. Translocation of bacteria or its end-products entering the liver could activate hepatocytes, Kupffer cells, and hepatic stellate cells, exacerbating hepatic steatosis, inflammation, and fibrosis. Bile acids regulate glucose and lipid metabolism through Farnesoid X receptors in the liver and intestine. Increased adipose tissue-derived non-esterified fatty acids would aggravate hepatic steatosis. Increased leptin also plays a role in hepatic fibrogenesis, and decreased adiponectin may contribute to hepatic insulin resistance. Moreover, dysregulation of peroxisome proliferator-activated receptors in the liver, adipose, and muscle tissues may impair lipid metabolism. In addition, the RAS may contribute to hepatic fatty acid metabolism, inflammation, and fibrosis. The treatment includes lifestyle modification, pharmacological therapy, and non-pharmacological therapy. Currently, weight reduction by lifestyle modification or surgery is the most effective therapy. However, vitamin E, pioglitazone, and obeticholic acid have also been suggested. In this review, we will introduce some new clinical trials and experimental therapies for the treatment of NASH and related fibrosis.
The initial presentation of non-alcoholic steatohepatitis (NASH) is hepatic steatosis. The dysfunction of lipid metabolism within hepatocytes caused by genetic factors, diet, and insulin resistance causes lipid accumulation. Lipotoxicity, oxidative stress, mitochondrial dysfunction, and endoplasmic reticulum stress would further contribute to hepatocyte injury and death, leading to inflammation and immune dysfunction in the liver. During the healing process, the accumulation of an excessive amount of fibrosis might occur while healing. During the development of NASH and liver fibrosis, the gut-liver axis, adipose-liver axis, and renin-angiotensin system (RAS) may be dysregulated and impaired. Translocation of bacteria or its end-products entering the liver could activate hepatocytes, Kupffer cells, and hepatic stellate cells, exacerbating hepatic steatosis, inflammation, and fibrosis. Bile acids regulate glucose and lipid metabolism through Farnesoid X receptors in the liver and intestine. Increased adipose tissue-derived non-esterified fatty acids would aggravate hepatic steatosis. Increased leptin also plays a role in hepatic fibrogenesis, and decreased adiponectin may contribute to hepatic insulin resistance. Moreover, dysregulation of peroxisome proliferator-activated receptors in the liver, adipose, and muscle tissues may impair lipid metabolism. In addition, the RAS may contribute to hepatic fatty acid metabolism, inflammation, and fibrosis. The treatment includes lifestyle modification, pharmacological therapy, and non-pharmacological therapy. Currently, weight reduction by lifestyle modification or surgery is the most effective therapy. However, vitamin E, pioglitazone, and obeticholic acid have also been suggested. In this review, we will introduce some new clinical trials and experimental therapies for the treatment of NASH and related fibrosis.The initial presentation of non-alcoholic steatohepatitis (NASH) is hepatic steatosis. The dysfunction of lipid metabolism within hepatocytes caused by genetic factors, diet, and insulin resistance causes lipid accumulation. Lipotoxicity, oxidative stress, mitochondrial dysfunction, and endoplasmic reticulum stress would further contribute to hepatocyte injury and death, leading to inflammation and immune dysfunction in the liver. During the healing process, the accumulation of an excessive amount of fibrosis might occur while healing. During the development of NASH and liver fibrosis, the gut-liver axis, adipose-liver axis, and renin-angiotensin system (RAS) may be dysregulated and impaired. Translocation of bacteria or its end-products entering the liver could activate hepatocytes, Kupffer cells, and hepatic stellate cells, exacerbating hepatic steatosis, inflammation, and fibrosis. Bile acids regulate glucose and lipid metabolism through Farnesoid X receptors in the liver and intestine. Increased adipose tissue-derived non-esterified fatty acids would aggravate hepatic steatosis. Increased leptin also plays a role in hepatic fibrogenesis, and decreased adiponectin may contribute to hepatic insulin resistance. Moreover, dysregulation of peroxisome proliferator-activated receptors in the liver, adipose, and muscle tissues may impair lipid metabolism. In addition, the RAS may contribute to hepatic fatty acid metabolism, inflammation, and fibrosis. The treatment includes lifestyle modification, pharmacological therapy, and non-pharmacological therapy. Currently, weight reduction by lifestyle modification or surgery is the most effective therapy. However, vitamin E, pioglitazone, and obeticholic acid have also been suggested. In this review, we will introduce some new clinical trials and experimental therapies for the treatment of NASH and related fibrosis.
Author Lee, Kuei-Chuan
Wu, Pei-Shan
Lin, Han-Chieh
Author_xml – sequence: 1
  givenname: Kuei-Chuan
  orcidid: 0000-0003-4318-5511
  surname: Lee
  fullname: Lee, Kuei-Chuan
– sequence: 2
  givenname: Pei-Shan
  surname: Wu
  fullname: Wu, Pei-Shan
– sequence: 3
  givenname: Han-Chieh
  orcidid: 0000-0003-3034-2637
  surname: Lin
  fullname: Lin, Han-Chieh
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36226471$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002917370$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNptUk1v1DAQtVARLaVHrigSF4SUxR9x7FyQqgralVYCQQ_crIntbLxN4sX2IvHvcfYD0Qr7YMvz3pvxvHmJziY_WYReE7xgjOMPeuwXFFO6wJSJZ-iCUilKKvmPs9NdUHmOrmLc4LwEprxhL9A5qymtK0Eu0OorpN6v7WSjiwVMpkjBQhrtlArfFTlfCYP2vR-cLmLKId_bLSSXjnCXYtG5NvjMf4WedzBEe3U8L9H3z5_ub-7K1Zfb5c31qtRc0lSCbjkYyjUHAk0HtZW8kkJaYMQ0bW2JYYCpxKyuMYAlXBNODLcdZcawS_T-oDqFTj1opzy4_bn26iGo62_3S0Vw3pzSDF4ewMbDRm2DGyH83jP2Dz6sFYTk9GBVIzpsKlHlRLaCDrdCVtC2vDUtUMHbrPXxoLXdtaM1OvcowPBI9HFkcn0u6pdqZMVrIbPAu6NA8D93NiY1uqjtMMBk_S6q7FbFZVXLJkPfPoFu_C5MuauKEco5IU01_-7NvxX9LeXkbwawA0Bng2KwndIuZff8XKAbcp_UPEgqD5KaB0nNg5RZ5RPWSfj_-D9XXMp2
CitedBy_id crossref_primary_10_26724_2079_8334_2025_1_91_101_105
crossref_primary_10_1021_acs_jafc_4c10239
crossref_primary_10_2147_JIR_S480574
crossref_primary_10_1111_apt_17889
crossref_primary_10_2174_0109298673320024240829070906
crossref_primary_10_3390_antiox13091026
crossref_primary_10_2478_aspr_2025_0010
crossref_primary_10_1016_j_intimp_2025_114020
crossref_primary_10_3748_wjg_v29_i32_4831
crossref_primary_10_3390_biomedicines11051295
crossref_primary_10_1016_j_livres_2025_04_004
crossref_primary_10_1186_s40104_025_01244_3
crossref_primary_10_3350_cmh_2023_0277
crossref_primary_10_21802_artm_2025_2_34_113
crossref_primary_10_3389_fendo_2025_1606654
crossref_primary_10_1002_mco2_70063
crossref_primary_10_2147_JIR_S503648
crossref_primary_10_3390_ijms25073694
crossref_primary_10_1186_s41043_025_01015_w
crossref_primary_10_1016_j_phymed_2025_157202
crossref_primary_10_3389_fnut_2025_1554392
crossref_primary_10_1016_j_diabres_2023_110993
crossref_primary_10_1186_s12944_023_01988_9
crossref_primary_10_2147_DMSO_S448165
crossref_primary_10_2174_0118715303326392241022050205
crossref_primary_10_1186_s12876_025_03778_2
crossref_primary_10_1016_j_jep_2025_119330
crossref_primary_10_1186_s12876_024_03538_8
crossref_primary_10_1080_17410541_2025_2476379
crossref_primary_10_1016_j_intimp_2025_115450
crossref_primary_10_1097_CM9_0000000000002753
crossref_primary_10_1038_s41598_025_03258_3
crossref_primary_10_1007_s00535_024_02181_0
crossref_primary_10_1186_s12944_025_02509_6
crossref_primary_10_1016_j_tox_2025_154137
crossref_primary_10_1097_JCMA_0000000000001266
crossref_primary_10_1016_j_foodres_2025_117281
crossref_primary_10_1016_j_jpha_2025_101318
crossref_primary_10_3390_cimb46070376
crossref_primary_10_3390_ijms26041778
crossref_primary_10_3390_ijms25063298
crossref_primary_10_1039_D4MD00420E
crossref_primary_10_3390_nu16040513
crossref_primary_10_1371_journal_pone_0303398
crossref_primary_10_1007_s42000_024_00593_4
crossref_primary_10_3350_cmh_2024_0113
crossref_primary_10_1017_S0967199423000400
crossref_primary_10_3390_nu16132160
crossref_primary_10_1016_j_jare_2025_08_067
crossref_primary_10_3389_fphar_2024_1428406
crossref_primary_10_1016_S1875_5364_24_60690_4
crossref_primary_10_3350_cmh_2023_0384
crossref_primary_10_3389_fnut_2024_1361567
crossref_primary_10_1002_jat_4767
crossref_primary_10_1186_s12944_025_02588_5
crossref_primary_10_3350_cmh_2022_0348
crossref_primary_10_1016_j_jep_2025_119358
crossref_primary_10_1016_j_biopha_2024_117297
crossref_primary_10_31146_1682_8658_ecg_229_9_75_85
crossref_primary_10_1007_s12602_025_10625_z
crossref_primary_10_3389_fimmu_2025_1599956
crossref_primary_10_3390_ijms242417514
crossref_primary_10_3389_fphys_2022_1106380
crossref_primary_10_3390_livers3040040
crossref_primary_10_3390_ncrna10040044
crossref_primary_10_1002_adhm_202303710
crossref_primary_10_3389_fmed_2024_1477820
crossref_primary_10_3389_fimmu_2025_1652741
crossref_primary_10_1097_MEG_0000000000002941
crossref_primary_10_1016_j_ijbiomac_2025_146449
crossref_primary_10_33549_physiolres_935453
crossref_primary_10_3389_fnut_2025_1530025
crossref_primary_10_1002_iid3_1114
crossref_primary_10_1016_j_jnutbio_2024_109807
crossref_primary_10_3390_ph17060729
crossref_primary_10_18229_kocatepetip_1591250
crossref_primary_10_3350_cmh_2025_0079
crossref_primary_10_3390_ijms241814292
crossref_primary_10_1016_j_aohep_2023_101281
crossref_primary_10_3390_cimb47060464
crossref_primary_10_4254_wjh_v16_i5_703
crossref_primary_10_1111_hepr_14087
crossref_primary_10_3350_cmh_2024_0818
crossref_primary_10_1016_j_biopha_2024_116585
crossref_primary_10_1016_j_jep_2024_118165
crossref_primary_10_1097_HM9_0000000000000117
crossref_primary_10_1016_j_metabol_2024_155912
crossref_primary_10_3389_fnut_2023_1276940
crossref_primary_10_1016_j_lfs_2024_122824
crossref_primary_10_1292_jvms_24_0313
crossref_primary_10_1002_mnfr_202300793
crossref_primary_10_1080_25787489_2025_2555065
crossref_primary_10_1016_j_tice_2024_102345
crossref_primary_10_1039_D3FO03858K
crossref_primary_10_1136_bmjdrc_2024_004514
crossref_primary_10_1186_s12902_024_01702_5
crossref_primary_10_1186_s40360_025_00898_z
crossref_primary_10_3389_fnut_2024_1340453
crossref_primary_10_1016_j_phrs_2025_107730
crossref_primary_10_1016_j_preme_2025_100043
crossref_primary_10_1134_S0006297924110130
crossref_primary_10_3390_ph17121724
crossref_primary_10_3892_ijmm_2024_5429
crossref_primary_10_1016_j_phymed_2025_156654
crossref_primary_10_3389_fmicb_2025_1517082
crossref_primary_10_1007_s11845_023_03529_w
crossref_primary_10_1016_j_envint_2025_109455
crossref_primary_10_1016_j_jsbmb_2025_106813
crossref_primary_10_1016_j_ejphar_2025_177817
crossref_primary_10_3389_fendo_2023_1150360
crossref_primary_10_1126_sciadv_adw2539
crossref_primary_10_1016_j_cbi_2024_111306
crossref_primary_10_1038_s41598_025_97670_4
crossref_primary_10_3350_cmh_2024_0558
crossref_primary_10_3390_antiox13121501
Cites_doi 10.1016/j.cgh.2018.07.006
10.1038/s41598-017-01751-y
10.1038/ncomms5309
10.1007/s00125-015-3769-3
10.3945/ajcn.114.094730
10.1016/j.jhep.2008.03.018
10.1001/jama.2014.10706
10.1053/j.gastro.2015.04.005
10.1038/s41591-021-01425-3
10.1016/j.jhep.2019.12.010
10.1056/nejmoa060326
10.1016/j.jhep.2015.07.010
10.1016/j.ccr.2012.02.007
10.1016/j.ebiom.2015.05.018
10.1002/hep4.1479
10.1172/jci200317797
10.1053/j.gastro.2020.11.051
10.1002/hep4.1601
10.1016/j.cgh.2013.02.015
10.1172/jci119248
10.1016/j.ccell.2016.05.020
10.1053/j.gastro.2008.06.047
10.1136/gutjnl-2011-301857
10.1016/j.jhep.2015.11.004
10.1172/jci89444
10.1038/s41575-019-0145-7
10.1096/fj.201601393r
10.1002/hep.29477
10.2337/db18-1193
10.1007/s11695-022-06150-5
10.1038/srep18899
10.1038/nature10809
10.1002/hep.29466
10.1002/hep.24242
10.1038/ijo.2017.21
10.1007/s00535-012-0739-0
10.1016/j.jhep.2020.02.027
10.1038/sj.ki.5000079
10.1016/s0140-6736(18)31785-9
10.3389/fendo.2021.635556
10.1055/s-0034-1377026
10.1016/j.jhepr.2019.10.006
10.1161/circresaha.117.312422
10.1038/nature16969
10.1016/j.jhep.2013.04.013
10.1016/j.jhep.2018.06.008
10.1038/nature03047
10.1172/jci23621
10.1158/0008-5472.can-17-0229
10.1016/j.jhep.2016.06.029
10.1016/j.ccell.2017.11.011
10.1002/hep.22183
10.1007/s00535-017-1415-1
10.1002/hep.26604
10.1016/j.cell.2015.01.012
10.1002/hep.1840380426
10.1016/j.jhep.2021.10.013
10.1016/j.jhep.2018.08.011
10.1001/jama.2021.19569
10.1007/s12072-020-10121-2
10.3390/cells10061562
10.1136/gutjnl-2021-326259
10.1016/j.coph.2019.09.006
10.1038/nm1663
10.1016/j.cmet.2011.11.004
10.1053/j.gastro.2013.05.042
10.1210/jc.2019-00160
10.1016/j.jhep.2019.08.005
10.1073/pnas.0601056103
10.1073/pnas.1323785111
10.1016/j.jhep.2014.03.014
10.1007/s11695-022-06011-1
10.1152/ajpgi.00265.2013
10.1002/hep.28289
10.1111/liv.12611
10.1002/hep.25967
10.1056/nejmoa1712191
10.1002/hep.25548
10.2337/db08-1637
10.1073/pnas.0808567105
10.1038/s41591-021-01495-3
10.1038/ajg.2010.488
10.3390/ijms18061134
10.1016/j.jhep.2017.02.037
10.1038/s41467-021-25701-5
10.1002/hep.510290632
10.1016/j.jhep.2007.04.019
10.1056/nejmoa2028395
10.1016/j.ccr.2014.07.001
10.1053/j.gastro.2015.12.037
10.1053/j.gastro.2016.01.032
10.1210/jc.2007-2524
10.1056/nejmoa2036205
10.1172/jci.insight.132158
10.1056/nejmoa0907929
10.1002/hep.31622
10.1016/j.jhep.2010.01.003
10.1016/j.jhep.2019.11.024
10.1186/s13148-015-0056-6
10.1126/science.3303333
10.1073/pnas.1217611110
10.1073/pnas.94.6.2557
10.1172/jci24930
10.1016/j.jhep.2011.08.018
10.1002/hep.24731
10.1056/nejmoa2029349
10.1016/j.hep.2003.09.028
10.1073/pnas.1920004117
10.1073/pnas.0506982103
10.1136/gutjnl-2014-308430
10.1002/hep.20283
10.1111/jgh.12510
10.1136/gutjnl-2021-325013
10.1111/apt.16596
10.1053/j.gastro.2010.03.052
10.1136/gutjnl-2014-306996
10.1194/jlr.r066357
10.1053/j.gastro.2007.10.039
10.1016/j.jhep.2009.03.019
10.1038/s41591-021-01489-1
10.1172/jci0214276
10.1038/ng.2901
10.1097/01.lab.0000069036.63405.5c
10.1016/s0140-6736(14)61933-4
10.1172/jci29069
10.1016/j.gie.2020.08.023
10.1101/gad.1083503
10.1371/journal.pone.0077817
10.1111/apt.12038
10.1002/hep.32294
10.1172/jci200422422
10.4137/jcd.s39824
10.1159/000282083
10.1002/mnfr.201900942
10.1093/hmg/ddp357
10.1053/j.gastro.2011.12.044
10.1002/hep.26319
10.1053/j.gastro.2019.11.296
10.1002/hep.20280
10.1136/gutjnl-2020-320853
10.1002/hep.29367
10.1007/s12072-020-10094-2
10.1136/gutjnl-2019-319104
10.1002/hep.30350
10.1016/j.cell.2009.12.052
10.1016/j.jhep.2014.02.030
10.14309/ajg.0000000000000661
10.1038/nm788
10.1172/jci28898
10.1007/s12072-021-10242-2
10.1002/hep.21763
10.1007/s11695-018-3525-0
10.1371/journal.pgen.1001324
10.1053/j.gastro.2009.06.051
10.1172/jci82204
10.1016/j.cgh.2018.10.017
10.1016/s0140-6736(15)00803-x
10.1016/j.cmet.2006.01.005
10.1002/hep.31423
10.1194/jlr.m085613
10.1016/j.cmet.2007.10.011
10.1002/hep.26093
10.1002/hep.23998
10.1055/s-0043-118666
10.1016/j.jhep.2017.11.014
10.1053/jhep.2001.28055
10.1002/hep.25534
10.1016/j.jhep.2016.08.023
10.1038/nature07976
10.1007/s10620-017-4470-9
10.1111/j.1478-3231.2008.01723.x
10.1002/hep.28899
10.1159/000447866
10.1016/j.cgh.2014.04.014
10.1194/jlr.p089953
10.1002/hep.31290
10.1038/ng.257
10.1053/j.gastro.2020.08.004
10.1016/j.jcmgh.2015.01.001
10.1038/s41419-020-03003-w
10.1038/s41591-021-01399-2
10.1016/j.cca.2012.12.007
10.1002/hep.510250428
10.1002/hep.20093
10.1007/s11010-010-0409-6
10.1016/s0140-6736(19)32517-6
10.1016/j.jcmgh.2021.05.017
10.1016/j.jhep.2022.04.003
10.1073/pnas.1808855115
10.1007/s11695-020-05084-0
10.1038/nature17041
10.1093/hmg/ddu121
10.1053/j.gastro.2021.03.021
10.1002/hep.29229
10.1016/j.cmet.2015.04.004
10.1016/j.cmet.2012.04.002
10.2220/biomedres.37.319
10.1016/j.cgh.2020.04.068
10.1210/jc.2004-1983
10.1016/j.cmet.2017.04.001
10.1002/hep.31108
10.1016/j.metabol.2013.09.013
10.1016/j.jhep.2019.08.016
10.1007/s00125-005-1682-x
10.1136/gutjnl-2017-315193
10.1002/hep.30368
10.1172/jci63539
10.1136/gut.2008.156307
ContentType Journal Article
Copyright 2023. This work is published under http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2023 by The Korean Association for the Study of the Liver 2023
Copyright_xml – notice: 2023. This work is published under http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2023 by The Korean Association for the Study of the Liver 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
ACYCR
DOI 10.3350/cmh.2022.0237
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

CrossRef
MEDLINE

Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: ProQuest Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2287-285X
EndPage 98
ExternalDocumentID oai_kci_go_kr_ARTI_10101522
oai_doaj_org_article_97f0d474d5ee4af0b784abb5bdba275b
PMC9845678
36226471
10_3350_cmh_2022_0237
Genre Journal Article
Review
GrantInformation_xml – fundername: Ministry of Science and Technology, Taiwan
  grantid: 111-2314-B-075-051-MY3
– fundername: Ministry of Science and Technology, Taiwan
  grantid: 110-2628-B-075-016
GroupedDBID 5-W
7X7
8FI
8FJ
8JR
8XY
9ZL
AAYXX
ABUWG
ACYCR
ADBBV
AFFHD
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
DIK
EBD
EF.
EMOBN
FYUFA
GROUPED_DOAJ
HMCUK
HYE
KQ8
M48
PGMZT
PHGZM
PHGZT
PIMPY
RNS
RPM
SV3
UKHRP
ADRAZ
CGR
CUY
CVF
ECM
EIF
IPNFZ
M~E
NPM
OK1
RIG
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c582t-acb5ad25c5a1a9fa6e854878ea31d9b6e1d3a02803660aae15c151d5ef23dd3
IEDL.DBID 7X7
ISICitedReferencesCount 133
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000981317100006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2287-2728
2287-285X
IngestDate Wed Mar 27 03:12:14 EDT 2024
Mon Nov 10 04:25:51 EST 2025
Tue Nov 04 02:06:47 EST 2025
Sun Nov 09 12:22:42 EST 2025
Tue Oct 07 07:06:01 EDT 2025
Thu Jan 02 22:54:09 EST 2025
Sat Nov 29 06:37:41 EST 2025
Tue Nov 18 22:28:11 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Steatohepatitis
Fatty liver
Liver fibrosis
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c582t-acb5ad25c5a1a9fa6e854878ea31d9b6e1d3a02803660aae15c151d5ef23dd3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
Editor: Dae Won Jun, Hanyang University College of Medicine, Korea
ORCID 0000-0003-3034-2637
0000-0003-4318-5511
OpenAccessLink https://www.proquest.com/docview/3125511942?pq-origsite=%requestingapplication%
PMID 36226471
PQID 3125511942
PQPubID 7084873
PageCount 22
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_10101522
doaj_primary_oai_doaj_org_article_97f0d474d5ee4af0b784abb5bdba275b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9845678
proquest_miscellaneous_2724584689
proquest_journals_3125511942
pubmed_primary_36226471
crossref_citationtrail_10_3350_cmh_2022_0237
crossref_primary_10_3350_cmh_2022_0237
PublicationCentury 2000
PublicationDate 2023-01-01
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
– name: Seoul
PublicationTitle Clinical and molecular hepatology
PublicationTitleAlternate Clin Mol Hepatol
PublicationYear 2023
Publisher Korean Association for the Study of the Liver
The Korean Association for the Study of the Liver
대한간학회
Publisher_xml – name: Korean Association for the Study of the Liver
– name: The Korean Association for the Study of the Liver
– name: 대한간학회
References ref57
ref207
ref56
ref208
ref59
ref205
ref58
ref206
ref53
ref203
ref52
ref204
ref55
ref201
ref54
ref202
ref210
ref211
ref51
ref50
ref46
ref45
ref48
ref216
ref47
ref217
ref42
ref214
ref41
ref215
ref44
ref212
ref43
ref213
ref49
ref8
ref7
ref9
ref4
ref3
ref6
ref5
ref100
ref101
ref40
ref35
ref34
ref37
ref36
ref31
ref30
ref33
ref32
ref39
ref38
ref24
ref23
ref26
ref25
ref20
ref21
ref28
ref27
ref29
Wirth (ref175) 2020
ref200
ref128
ref129
ref97
ref126
ref96
ref127
ref99
ref124
ref98
ref125
ref93
ref133
ref92
Mao (ref94) 2015
ref134
ref95
ref131
ref132
ref130
ref91
Younossi (ref209) 2019
ref90
ref89
ref139
ref86
ref85
ref138
ref88
ref135
ref87
ref136
ref82
ref144
ref81
ref145
ref84
ref142
ref83
ref143
ref140
ref141
ref80
ref79
ref108
ref78
ref109
ref106
ref107
ref75
ref104
ref74
ref105
ref77
ref102
ref76
ref103
ref71
ref111
ref70
ref112
ref73
ref72
ref110
ref68
ref119
ref67
ref117
ref69
ref118
ref64
ref115
ref63
ref116
ref66
ref113
ref65
ref114
Wijarnpreecha (ref167) 2017
Chambers (ref22) 2011
ref60
ref122
ref123
ref62
ref120
ref61
ref121
ref168
ref169
ref170
ref177
ref178
ref176
ref173
ref174
ref171
ref172
ref179
ref180
ref181
ref188
ref189
ref186
ref187
ref184
ref185
ref182
ref183
Marchesini (ref13) 2001
ref148
ref149
ref146
ref147
ref155
ref156
ref153
ref154
ref151
ref152
ref150
Huang (ref137) 2006
Utzschneider (ref16) 2006
ref159
ref157
ref158
Harrison (ref191)
ref166
ref164
ref165
ref162
ref163
ref160
ref161
ref12
ref15
ref14
ref11
ref10
ref17
ref19
ref18
ref2
ref1
ref192
ref190
ref199
ref197
ref198
ref195
ref196
ref193
ref194
References_xml – ident: ref64
  doi: 10.1016/j.cgh.2018.07.006
– ident: ref183
  doi: 10.1038/s41598-017-01751-y
– ident: ref86
  doi: 10.1038/ncomms5309
– ident: ref122
  doi: 10.1007/s00125-015-3769-3
– ident: ref6
  doi: 10.3945/ajcn.114.094730
– ident: ref131
  doi: 10.1016/j.jhep.2008.03.018
– ident: ref171
  doi: 10.1001/jama.2014.10706
– ident: ref161
  doi: 10.1053/j.gastro.2015.04.005
– ident: ref199
  doi: 10.1038/s41591-021-01425-3
– ident: ref211
  doi: 10.1016/j.jhep.2019.12.010
– ident: ref188
  doi: 10.1056/nejmoa060326
– ident: ref12
  doi: 10.1016/j.jhep.2015.07.010
– ident: ref153
  doi: 10.1016/j.ccr.2012.02.007
– ident: ref54
  doi: 10.1016/j.ebiom.2015.05.018
– ident: ref67
  doi: 10.1002/hep4.1479
– ident: ref118
  doi: 10.1172/jci200317797
– ident: ref158
  doi: 10.1053/j.gastro.2020.11.051
– ident: ref185
  doi: 10.1002/hep4.1601
– ident: ref92
  doi: 10.1016/j.cgh.2013.02.015
– ident: ref17
  doi: 10.1172/jci119248
– ident: ref146
  doi: 10.1016/j.ccell.2016.05.020
– ident: ref189
  doi: 10.1053/j.gastro.2008.06.047
– ident: ref74
  doi: 10.1136/gutjnl-2011-301857
– ident: ref156
  doi: 10.1016/j.jhep.2015.11.004
– ident: ref7
  doi: 10.1172/jci89444
– ident: ref141
  doi: 10.1038/s41575-019-0145-7
– ident: ref55
  doi: 10.1096/fj.201601393r
– ident: ref212
  doi: 10.1002/hep.29477
– ident: ref29
  doi: 10.2337/db18-1193
– ident: ref182
  doi: 10.1007/s11695-022-06150-5
– ident: ref134
  doi: 10.1038/srep18899
– start-page: 1844
  volume-title: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
  year: 2001
  ident: ref13
– ident: ref96
  doi: 10.1038/nature10809
– ident: ref140
  doi: 10.1002/hep.29466
– ident: ref155
  doi: 10.1002/hep.24242
– ident: ref33
  doi: 10.1038/ijo.2017.21
– ident: ref145
  doi: 10.1007/s00535-012-0739-0
– ident: ref205
  doi: 10.1016/j.jhep.2020.02.027
– ident: ref136
  doi: 10.1038/sj.ki.5000079
– ident: ref198
  doi: 10.1016/s0140-6736(18)31785-9
– start-page: 4753
  volume-title: Review: the role of insulin resistance in nonalcoholic fatty liver disease
  year: 2006
  ident: ref16
– ident: ref196
  doi: 10.3389/fendo.2021.635556
– ident: ref116
  doi: 10.1055/s-0034-1377026
– ident: ref181
  doi: 10.1016/j.jhepr.2019.10.006
– ident: ref139
  doi: 10.1161/circresaha.117.312422
– ident: ref147
  doi: 10.1038/nature16969
– ident: ref160
  doi: 10.1016/j.jhep.2013.04.013
– start-page: 1131
  volume-title: Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma
  year: 2011
  ident: ref22
– ident: ref37
  doi: 10.1016/j.jhep.2018.06.008
– ident: ref19
  doi: 10.1038/nature03047
– ident: ref15
  doi: 10.1172/jci23621
– ident: ref149
  doi: 10.1158/0008-5472.can-17-0229
– ident: ref26
  doi: 10.1016/j.jhep.2016.06.029
– ident: ref150
  doi: 10.1016/j.ccell.2017.11.011
– ident: ref47
  doi: 10.1002/hep.22183
– ident: ref187
  doi: 10.1007/s00535-017-1415-1
– ident: ref77
  doi: 10.1002/hep.26604
– ident: ref128
  doi: 10.1016/j.cell.2015.01.012
– ident: ref44
  doi: 10.1002/hep.1840380426
– ident: ref28
  doi: 10.1016/j.jhep.2021.10.013
– ident: ref159
  doi: 10.1016/j.jhep.2018.08.011
– ident: ref177
  doi: 10.1001/jama.2021.19569
– ident: ref60
  doi: 10.1007/s12072-020-10121-2
– ident: ref101
  doi: 10.3390/cells10061562
– start-page: e8
  volume-title: Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis
  year: 2017
  ident: ref167
– ident: ref148
  doi: 10.1136/gutjnl-2021-326259
– ident: ref3
  doi: 10.1016/j.coph.2019.09.006
– ident: ref102
  doi: 10.1038/nm1663
– ident: ref42
  doi: 10.1016/j.cmet.2011.11.004
– ident: ref208
  doi: 10.1053/j.gastro.2013.05.042
– ident: ref9
  doi: 10.1210/jc.2019-00160
– ident: ref104
  doi: 10.1016/j.jhep.2019.08.005
– ident: ref107
  doi: 10.1073/pnas.0601056103
– ident: ref25
  doi: 10.1073/pnas.1323785111
– ident: ref103
  doi: 10.1016/j.jhep.2014.03.014
– ident: ref174
  doi: 10.1007/s11695-022-06011-1
– ident: ref111
  doi: 10.1152/ajpgi.00265.2013
– ident: ref71
  doi: 10.1002/hep.28289
– ident: ref129
  doi: 10.1111/liv.12611
– ident: ref46
  doi: 10.1002/hep.25967
– ident: ref87
  doi: 10.1056/nejmoa1712191
– ident: ref169
  doi: 10.1002/hep.25548
– ident: ref113
  doi: 10.2337/db08-1637
– ident: ref112
  doi: 10.1073/pnas.0808567105
– ident: ref201
  doi: 10.1038/s41591-021-01495-3
– ident: ref170
  doi: 10.1038/ajg.2010.488
– ident: ref53
  doi: 10.3390/ijms18061134
– ident: ref27
  doi: 10.1016/j.jhep.2017.02.037
– ident: ref206
  doi: 10.1038/s41467-021-25701-5
– ident: ref79
  doi: 10.1002/hep.510290632
– ident: ref99
  doi: 10.1016/j.jhep.2007.04.019
– ident: ref195
  doi: 10.1056/nejmoa2028395
– ident: ref144
  doi: 10.1016/j.ccr.2014.07.001
– ident: ref69
  doi: 10.1053/j.gastro.2015.12.037
– ident: ref82
  doi: 10.1053/j.gastro.2016.01.032
– ident: ref5
  doi: 10.1210/jc.2007-2524
– ident: ref193
  doi: 10.1056/nejmoa2036205
– ident: ref89
  doi: 10.1172/jci.insight.132158
– ident: ref204
  doi: 10.1056/nejmoa0907929
– ident: ref216
  doi: 10.1002/hep.31622
– ident: ref39
  doi: 10.1016/j.jhep.2010.01.003
– ident: ref210
  doi: 10.1016/j.jhep.2019.11.024
– ident: ref91
  doi: 10.1186/s13148-015-0056-6
– ident: ref162
  doi: 10.1126/science.3303333
– ident: ref40
  doi: 10.1073/pnas.1217611110
– ident: ref98
  doi: 10.1073/pnas.94.6.2557
– ident: ref18
  doi: 10.1172/jci24930
– ident: ref165
  doi: 10.1016/j.jhep.2011.08.018
– start-page: 2184
  volume-title: Obeticholic acid for the treatment of nonalcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
  year: 2019
  ident: ref209
– ident: ref166
  doi: 10.1002/hep.24731
– ident: ref63
  doi: 10.1056/nejmoa2029349
– ident: ref163
  doi: 10.1016/j.hep.2003.09.028
– ident: ref127
  doi: 10.1073/pnas.1920004117
– ident: ref108
  doi: 10.1073/pnas.0506982103
– ident: ref152
  doi: 10.1136/gutjnl-2014-308430
– ident: ref56
  doi: 10.1002/hep.20283
– ident: ref105
  doi: 10.1111/jgh.12510
– ident: ref41
  doi: 10.1136/gutjnl-2021-325013
– ident: ref192
  doi: 10.1111/apt.16596
– ident: ref100
  doi: 10.1053/j.gastro.2010.03.052
– ident: ref30
  doi: 10.1136/gutjnl-2014-306996
– ident: ref57
  doi: 10.1194/jlr.r066357
– ident: ref38
  doi: 10.1053/j.gastro.2007.10.039
– ident: ref66
  doi: 10.1016/j.jhep.2009.03.019
– ident: ref200
  doi: 10.1038/s41591-021-01489-1
– ident: ref135
  doi: 10.1172/jci0214276
– start-page: 32
  volume-title: Bariatric surgery is associated with decreased progression of nonalcoholic fatty liver disease to cirrhosis: a retrospective cohort analysis
  year: 2020
  ident: ref175
– ident: ref24
  doi: 10.1038/ng.2901
– ident: ref70
  doi: 10.1097/01.lab.0000069036.63405.5c
– ident: ref207
  doi: 10.1016/s0140-6736(14)61933-4
– ident: ref124
  doi: 10.1172/jci29069
– ident: ref180
  doi: 10.1016/j.gie.2020.08.023
– ident: ref109
  doi: 10.1101/gad.1083503
– ident: ref133
  doi: 10.1371/journal.pone.0077817
– ident: ref11
  doi: 10.1111/apt.12038
– ident: ref130
  doi: 10.1002/hep.32294
– ident: ref2
  doi: 10.1172/jci200422422
– ident: ref61
  doi: 10.4137/jcd.s39824
– start-page: 3648
  volume-title: Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease
  year: 2015
  ident: ref94
– ident: ref125
  doi: 10.1159/000282083
– ident: ref48
  doi: 10.1002/mnfr.201900942
– ident: ref23
  doi: 10.1093/hmg/ddp357
– ident: ref83
  doi: 10.1053/j.gastro.2011.12.044
– ident: ref93
  doi: 10.1002/hep.26319
– ident: ref214
  doi: 10.1053/j.gastro.2019.11.296
– ident: ref119
  doi: 10.1002/hep.20280
– ident: ref84
  doi: 10.1136/gutjnl-2020-320853
– ident: ref1
  doi: 10.1002/hep.29367
– ident: ref157
  doi: 10.1007/s12072-020-10094-2
– ident: ref215
  doi: 10.1136/gutjnl-2019-319104
– ident: ref90
  doi: 10.1002/hep.30350
– ident: ref143
  doi: 10.1016/j.cell.2009.12.052
– ident: ref154
  doi: 10.1016/j.jhep.2014.02.030
– ident: ref186
  doi: 10.14309/ajg.0000000000000661
– ident: ref117
  doi: 10.1038/nm788
– ident: ref75
  doi: 10.1172/jci28898
– ident: ref190
  doi: 10.1007/s12072-021-10242-2
– ident: ref10
  doi: 10.1002/hep.21763
– ident: ref172
  doi: 10.1007/s11695-018-3525-0
– ident: ref21
  doi: 10.1371/journal.pgen.1001324
– ident: ref191
– ident: ref72
  doi: 10.1053/j.gastro.2009.06.051
– ident: ref45
  doi: 10.1172/jci82204
– ident: ref173
  doi: 10.1016/j.cgh.2018.10.017
– ident: ref194
  doi: 10.1016/s0140-6736(15)00803-x
– ident: ref32
  doi: 10.1016/j.cmet.2006.01.005
– ident: ref35
  doi: 10.1002/hep.31423
– ident: ref49
  doi: 10.1194/jlr.m085613
– ident: ref132
  doi: 10.1016/j.cmet.2007.10.011
– ident: ref115
  doi: 10.1002/hep.26093
– ident: ref73
  doi: 10.1002/hep.23998
– ident: ref126
  doi: 10.1055/s-0043-118666
– ident: ref68
  doi: 10.1016/j.jhep.2017.11.014
– ident: ref78
  doi: 10.1053/jhep.2001.28055
– ident: ref123
  doi: 10.1002/hep.25534
– ident: ref168
  doi: 10.1016/j.jhep.2016.08.023
– ident: ref58
  doi: 10.1038/nature07976
– ident: ref80
  doi: 10.1007/s10620-017-4470-9
– ident: ref97
  doi: 10.1111/j.1478-3231.2008.01723.x
– ident: ref8
  doi: 10.1002/hep.28899
– ident: ref76
  doi: 10.1159/000447866
– ident: ref65
  doi: 10.1016/j.cgh.2014.04.014
– ident: ref88
  doi: 10.1194/jlr.p089953
– ident: ref85
  doi: 10.1002/hep.31290
– ident: ref20
  doi: 10.1038/ng.257
– ident: ref197
  doi: 10.1053/j.gastro.2020.08.004
– ident: ref106
  doi: 10.1016/j.jcmgh.2015.01.001
– ident: ref62
  doi: 10.1038/s41419-020-03003-w
– ident: ref184
  doi: 10.1038/s41591-021-01399-2
– start-page: 105
  volume-title: Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptormediated, angiotensin II-independent mechanisms
  year: 2006
  ident: ref137
– ident: ref120
  doi: 10.1016/j.cca.2012.12.007
– ident: ref52
  doi: 10.1002/hep.510250428
– ident: ref164
  doi: 10.1002/hep.20093
– ident: ref50
  doi: 10.1007/s11010-010-0409-6
– ident: ref202
  doi: 10.1016/s0140-6736(19)32517-6
– ident: ref138
  doi: 10.1016/j.jcmgh.2021.05.017
– ident: ref217
  doi: 10.1016/j.jhep.2022.04.003
– ident: ref31
  doi: 10.1073/pnas.1808855115
– ident: ref178
  doi: 10.1007/s11695-020-05084-0
– ident: ref36
  doi: 10.1038/nature17041
– ident: ref81
  doi: 10.1093/hmg/ddu121
– ident: ref176
  doi: 10.1053/j.gastro.2021.03.021
– ident: ref59
  doi: 10.1002/hep.29229
– ident: ref43
  doi: 10.1016/j.cmet.2015.04.004
– ident: ref51
  doi: 10.1016/j.cmet.2012.04.002
– ident: ref110
  doi: 10.2220/biomedres.37.319
– ident: ref179
  doi: 10.1016/j.cgh.2020.04.068
– ident: ref4
  doi: 10.1210/jc.2004-1983
– ident: ref114
  doi: 10.1016/j.cmet.2017.04.001
– ident: ref213
  doi: 10.1002/hep.31108
– ident: ref121
  doi: 10.1016/j.metabol.2013.09.013
– ident: ref142
  doi: 10.1016/j.jhep.2019.08.016
– ident: ref14
  doi: 10.1007/s00125-005-1682-x
– ident: ref151
  doi: 10.1136/gutjnl-2017-315193
– ident: ref203
  doi: 10.1002/hep.30368
– ident: ref34
  doi: 10.1172/jci63539
– ident: ref95
  doi: 10.1136/gut.2008.156307
SSID ssj0000702593
Score 2.5993016
SecondaryResourceType review_article
Snippet The initial presentation of non-alcoholic steatohepatitis (NASH) is hepatic steatosis. The dysfunction of lipid metabolism within hepatocytes caused by genetic...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 77
SubjectTerms Autophagy
Body fat
Diet
Exercise
Fatty acids
Fatty liver
Fibrosis - etiology
Humans
Inflammation
Inflammation - metabolism
Inflammation - pathology
Insulin Resistance
Kinases
Lipids
Liver - pathology
Liver cancer
Liver cirrhosis
Liver diseases
liver fibrosis
Metabolism
MicroRNAs
Non-alcoholic Fatty Liver Disease - drug therapy
Non-alcoholic Fatty Liver Disease - pathology
Non-alcoholic Fatty Liver Disease - therapy
Obesity
Overweight
Oxidation
Oxidative stress
Pathogenesis
Phosphorylation
Proteins
Review
Sedentary behavior
steatohepatitis
내과학
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9UwDLfQhBAXBOOrsKEiECfK2qRpkiNDm0CCaRIcdovyuVUbLXqv4-_HbrvqPQTiwilS40jpz05s164N8FryiEpX-4In5Ypacl3YMpYF_b1sVRPqGOux2YQ8OVFnZ_p0o9UX5YRN5YEn4A60TGWoZR0ErrKpdFLV1jnhgrNMCke3byn1hjM13sESdflYcZehS1AwydRUYJNzUR747xSGYOwdKiy5pZDGuv2oZrpV-pPJ-Xvm5IYqOr4P92YbMn8_7f0B3IrdLtz5MkfJH8LnUzTr-nO6xdp1bruQL-nkeZ9ydPgLO3XGbX1OXB76i0iZ1cNM3g7rPKEf3eP6R_D1-Ojbh4_F3DWh8EKxobDeCRuY8MJWVifbREVeiYqWV0G7JlaBWwqo8qYprY2V8Kj1Ed7EeAj8MezgNuJTyCNnPnnHeRmQATaha1XjyGOjpRBOZfD2Bjjj54Li1NfiyqBjQTgbxNkQzoZwzuDNQv5jqqTxN8JD4sJCRAWwxwcoFmYWC_MvscjgFfLQXPp2XE_jeW8uVwbdhE-U14ZmEGMZ7N3w2Mxnd2042nwUXa1x-uUyjaeOQim2i_312qBAUYC5UTqDJ5NILPtFkwCtTFllILeEZeuFtme69mKs7K0V2rNSPfsfCDyHuwgpnz4X7cHOsLqO-3Db_0RZWr0Yj8svmfIawQ
  priority: 102
  providerName: Directory of Open Access Journals
Title Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
URI https://www.ncbi.nlm.nih.gov/pubmed/36226471
https://www.proquest.com/docview/3125511942
https://www.proquest.com/docview/2724584689
https://pubmed.ncbi.nlm.nih.gov/PMC9845678
https://doaj.org/article/97f0d474d5ee4af0b784abb5bdba275b
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002917370
Volume 29
WOSCitedRecordID wos000981317100006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Clinical and Molecular Hepatology, 2023, 29(1), , pp.77-98
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2287-285X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000702593
  issn: 2287-2728
  databaseCode: DOA
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2287-285X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000702593
  issn: 2287-2728
  databaseCode: 7X7
  dateStart: 20110301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2287-285X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000702593
  issn: 2287-2728
  databaseCode: BENPR
  dateStart: 20110301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content Database
  customDbUrl:
  eissn: 2287-285X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000702593
  issn: 2287-2728
  databaseCode: PIMPY
  dateStart: 20110301
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BixAX3o9AWQWBOJE2a8exc0IUtaISXUXAYTlZfmUbFZKyu-X3M5NkA4uAC5dESRxpnPnseWYG4IXkAYVu4RJeKZtkkheJSUOa0N_LRuU-CyHrmk3I2UzN50U5ONxWQ1rlZk_sNmrfOvKRH3CUxBTzytjri28JdY2i6OrQQuMq7FLbbMK5nMvRx4JwZn3dXYaGQcIkU32ZTc5FeuC-UjCCsX0UW3JLLHXV-1HYNMvqT4rn7_mTvwik41v_O5XbcHNQReM3PXbuwJXQ3IXrp0Ow_R68L1E7bBe0Gdar2DQ-HrPS47aKm7ZJTN9gt3YxgWXdngVK0F4Pw-v1Kq7QHG_x_fvw8fjo09t3ydB8IXFCsXVinBXGM-GEmZqiMnlQZNyoYPjUFzYPU88NxWV5nqfGhKlwqDx4ESrGvecPYAfJCI8gDpy5ylnOU-8zaSq00DI885AXUgirIni1-fLaDXXJqT3GF432CTFKI6M0MUoToyJ4OQ6_6Aty_G3gIbFxHER1tLsb7XKhh2WpC1mlSFWGdIfMVKmVKjPWCuutYVLYCJ4jCPS5q7v36bxo9flSo7VxQulxqE0xFsHehtF62AJW-ieXI3g2PsbFSxEZ04T2cqURkRSnzlURwcMeUyO9qFmgsiqnEcgttG1NaPtJU591BcILhWqxVI__TdYTuIEfi_f-pD3YWS8vw1O45r4jSpaTbiV1RzWB3cOjWflh0jks8Ko8OS0__wBoMSw6
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoAL70egQBCPE6FZO4mdA0K8qq66rSrRw56w_Mo2KiRlswXxn_iRzCTZwCLg1gOnSLETje3P8_CMZwAeC-5R6OY24oU0USJ4HunYxxHdXtYyc4n3SVtsQuztyek031-D78u7MBRWueSJLaN2taUz8k2Okph8Xgl7efw5oqpR5F1dltDoYLHjv31Fk615MX6L6_uEsa13B2-2o76qQGRTyRaRtibVjqU21SOdFzrzkrR26TUfudxkfuS4Jocjz7JYaz9KLUpFl_qCcec4_vUMnEUuLsjUE1MxnOjg5mFdll-GZkjEBJNdUk_O03jTfiLXB2PPUUiKFSHY1gpA0VbNiz-pub9Ha_4i_rYu_18TdwUu9Wp2-KrbF1dhzVfX4PxuH0hwHSb7qPnWM2L0ZRPqyoVDxH1YF2FVV5HuigeXNqSNsKgPPQWfL_ru5aIJi9Lg9JbNDXh_CiO5CetIhr8NoefMFtZwHjuXCF2g9Zngk_ssF2lqZADPluusbJ9znUp_fFRoexEsFMJCESwUwSKAp0P34y7ZyN86vibQDJ0oR3j7op7PVM9yVC6KGKlKkG6f6CI2QibamNQ4o5lITQCPEHLqyJbt9_Sc1eportCSGlPoH2qKjAWwsYSV6tlbo35iKoCHQzMyJvI26crXJ41C_JMPPpN5ALc6BA_0otaEirgYBSBWsL0yoNWWqjxsk5_nElV-Ie_8m6wHcGH7YHeiJuO9nbtwESeOd-dmG7C-mJ_4e3DOfkHEzO-3eziED6eL_B8HoIPg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pathogenesis+and+treatment+of+non-alcoholic+steatohepatitis+and+its+fibrosis&rft.jtitle=Clinical+and+molecular+hepatology&rft.au=Lee%2C+Kuei-Chuan&rft.au=Wu%2C+Pei-Shan&rft.au=Lin%2C+Han-Chieh&rft.date=2023-01-01&rft.pub=The+Korean+Association+for+the+Study+of+the+Liver&rft.issn=2287-2728&rft.eissn=2287-285X&rft.volume=29&rft.issue=1&rft.spage=77&rft.epage=98&rft_id=info:doi/10.3350%2Fcmh.2022.0237&rft_id=info%3Apmid%2F36226471&rft.externalDocID=PMC9845678
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-2728&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-2728&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-2728&client=summon